Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic Rhinitis

Summary

RV568 is being developed for the treatment of diseases such as asthma, COPD and allergic rhinitis (e.g. hayfever). The main aim of this study is to investigate whether RV568 ameliorates the nasal symptoms to low doses of grass pollen in healthy subjects with seasonal allergic rhinitis.

Timeline

Start

2010-10

Primary completion

2010-11

Completion

2010-12

Drugs

Indications